The downstream IT solutions provider Implico Group is the market leader for terminal automation systems (TMS) in Europe, the Middle East and Africa (EMEA). This has been confirmed by the results of the ARC Advisory Group’s recently published bi-annual market study. 

The Implico Group was first acknowledged as leading provider of terminal automation software in the EMEA region in 2010. 

According to the ARC Study 2020: “Current estimates indicate that the EMEA region is the largest single market in the world.” 

Besides the number one position in EMEA, the paper also lists the Implico Group as one of the top three providers of terminal automation solutions and services worldwide. 

The Implico Group develops and distributes the “feature-rich terminal management system” OpenTAS, which provides a comprehensive package of solutions for automating processes in bulk liquid storage facilities. In 2019, the company then added another TMS to its portfolio – QINO, developed by the Implico Group’s Dutch subsidiary, Brainum. 

Both OpenTAS and QINO support all means of transport. Together, they cater to tank farms of all sizes. Going forward, the Implico Group will further expand the cloud functionalities of its terminal automation systems and enrich them with web-based micro-services that address key business challenges. These micro-services are embedded in a broad, future-proof framework called the Supply Chain United (SCU).

“We are very pleased with the Implico Group’s prominent position in the ARC Study 2020,” said CEO Tim Hoffmeister. “We work hard to ensure that our solutions and services offer our customers decisive business benefits and lasting value – today as well as tomorrow. We also constantly push forward to expand our global presence and footprint. 

“In this regard, we are sure that our recently formed partnerships will help us to not only strengthen our market leadership in EMEA, but also gain an even stronger foothold in other key regions of the world.”

For more information visit www.implico.com

11th March 2021